title: [Eruptive nevi after injection of drugs marketed as melanotan II. The first two Swedish cases described].
authors: Ewa
authors: E
authors: Burian
authors: Elzbieta
authors: E
authors: Burian
mesh_terms: D000328:Adult; D015198:Designer Drugs / Q000009:adverse effects; D004416:Dysplastic Nevus Syndrome / Q000139:chemically induced* / Q000473:pathology; D005260:Female; D006801:Humans; D013287:Illicit Drugs / Q000009:adverse effects; D007279:Injections, Subcutaneous; D008297:Male; D009508:Nevus, Pigmented / Q000139:chemically induced / Q000473:pathology; D010456:Peptides, Cyclic / Q000009:adverse effects* / Q000494:pharmacology; D012880:Skin Pigmentation / Q000187:drug effects; D013548:Sweden; D000521:alpha-MSH / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000494:pharmacology
chemical_list: D015198:Designer Drugs; D013287:Illicit Drugs; D010456:Peptides, Cyclic; C079282:melanotan-II; D000521:alpha-MSH